FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, namely to pharmacology and cardiology, and deals with correction of endothelial dysfunction. For this purpose medication, which represents activated potentiated form of antibodies to interleukins, is introduced.
EFFECT: introduction of said medication, activity of which is conditioned by the process of multiple successive dilution in water or water-alcohol solvent in combination with external mechanic influence - vertical shacking of each dilution, ensures effective correction of endothelial dysfunction.
8 cl, 3 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2541166C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543331C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543332C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2542403C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2526149C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2500424C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2527689C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF INTERLEUKIN-1 ANTIBODIES | 2011 |
|
RU2526150C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF INTERLEUKIN-6 ANTIBODIES | 2011 |
|
RU2477530C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE ANTIBODIES IN COMPLEX WITH SOLUTION OF HOMOEOPATHIC DILUTIONS OF ANGIOTENSIN II RECEPTOR C-TERMINAL FRAGMENT ANTIBODIES | 2011 |
|
RU2500425C2 |
